Avellino Labs is a global leader in gene therapy and molecular diagnostics, and the pioneer in personalized medicine for eye care. Avellino Labs is pioneering CRISPR gene editing to manage and potentially cure inherited diseases. Avellino Labs continues to expand its diagnostics capabilities, building on the success of the world's first DNA test to confirm the presence of genetic indicators that are positively associated with corneal dystrophies, providing life-changing information for patient treatment decisions and follow up care. Avellino Labs is headquartered in Silicon Valley, California, with operations in Korea, Japan, China and the UK.

Biotechnology

Avellino Labs

Thomas Kim

Shveta Bidani

Murat Sönmez

Elizabeth Yeu

Nancy Selph

Scott Korney

Cyril Allouche

Horiuchi Nobuhide

Prabal Chatterjee

Jason Junghan Kim

Genya Dana

John Hong

Eric Bernabei

The Regional Management team at Avellino Labs oversees and coordinates the company's operations in the Asia-Pacific region, with key members responsible for commercial strategies and regional market expansion in Korea and Japan. This team ensures alignment with corporate objectives, drives regional business growth, and manages strategic partnerships to support Avellino's mission of advancing personalized medicine and gene therapy in eye care.

Regional Management

Scientific & Medical Advisory Team

Leadership Team

Board Members

Regional Management

About

Team members

Other teams at Avellino Labs

Scientific & Medical Advisory Team

Leadership Team

Board Members